<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35412435</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1933-6969</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>16</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Channels (Austin, Tex.)</Title>
          <ISOAbbreviation>Channels (Austin)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Capsaicin as an amphipathic modulator of Na<sub>V</sub>1.5 mechanosensitivity.</ArticleTitle>
        <Pagination>
          <StartPage>9</StartPage>
          <EndPage>26</EndPage>
          <MedlinePgn>9-26</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/19336950.2022.2026015</ELocationID>
        <Abstract>
          <AbstractText><i>SCN5A</i>-encoded Na<sub>V</sub>1.5 is a voltage-gated Na<sup>+</sup> channel that drives the electrical excitability of cardiac myocytes and contributes to slow waves of the human gastrointestinal smooth muscle cells. Na<sub>V</sub>1.5 is mechanosensitive: mechanical force modulates several facets of Na<sub>V</sub>1.5's voltage-gated function, and some Na<sub>V</sub>1.5 channelopathies are associated with abnormal Na<sub>V</sub>1.5 mechanosensitivity (MS). A class of membrane-active drugs, known as amphiphiles, therapeutically target Na<sub>V</sub>1.5's voltage-gated function and produce off-target effects including alteration of MS. Amphiphiles may provide a novel option for therapeutic modulation of Na<sub>V</sub>1.5's mechanosensitive operation. To more selectively target Na<sub>V</sub>1.5 MS, we searched for a membrane-partitioning amphipathic agent that would inhibit MS with minimal closed-state inhibition of voltage-gated currents. Among the amphiphiles tested, we selected capsaicin for further study. We used two methods to assess the effects of capsaicin on Na<sub>V</sub>1.5 MS: (1) membrane suction in cell-attached macroscopic patches and (2) fluid shear stress on whole cells. We tested the effect of capsaicin on Na<sub>V</sub>1.5 MS by examining macro-patch and whole-cell Na<sup>+</sup> current parameters with and without force. Capsaicin abolished the pressure- and shear-mediated peak current increase and acceleration; and the mechanosensitive shifts in the voltage-dependence of activation (shear) and inactivation (pressure and shear). Exploring the recovery from inactivation and use-dependent entry into inactivation, we found divergent stimulus-dependent effects that could potentiate or mitigate the effect of capsaicin, suggesting that mechanical stimuli may differentially modulate Na<sub>V</sub>1.5 MS. We conclude that selective modulation of Na<sub>V</sub>1.5 MS makes capsaicin a promising candidate for therapeutic interventions targeting MS.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cowan</LastName>
            <ForeName>Luke M</ForeName>
            <Initials>LM</Initials>
            <Identifier Source="ORCID">0000-0002-5512-1227</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Enteric Neuroscience Program (ENSP), Mayo Clinic, Rochester, MN, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Mn, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Strege</LastName>
            <ForeName>Peter R</ForeName>
            <Initials>PR</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Enteric Neuroscience Program (ENSP), Mayo Clinic, Rochester, MN, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Mn, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rusinova</LastName>
            <ForeName>Radda</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Andersen</LastName>
            <ForeName>Olaf S</ForeName>
            <Initials>OS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Farrugia</LastName>
            <ForeName>Gianrico</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Enteric Neuroscience Program (ENSP), Mayo Clinic, Rochester, MN, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Mn, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beyder</LastName>
            <ForeName>Arthur</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-9225-4854</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Enteric Neuroscience Program (ENSP), Mayo Clinic, Rochester, MN, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Mn, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>DP2 AT010875</GrantID>
            <Acronym>AT</Acronym>
            <Agency>NCCIH NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>K08 DK106456</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK052766</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 GM021342</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Channels (Austin)</MedlineTA>
        <NlmUniqueID>101321614</NlmUniqueID>
        <ISSNLinking>1933-6950</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D062554">NAV1.5 Voltage-Gated Sodium Channel</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9NEZ333N27</RegistryNumber>
          <NameOfSubstance UI="D012964">Sodium</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>S07O44R1ZM</RegistryNumber>
          <NameOfSubstance UI="D002211">Capsaicin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002211" MajorTopicYN="N">Capsaicin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053447" MajorTopicYN="Y">Channelopathies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D032383" MajorTopicYN="N">Myocytes, Cardiac</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062554" MajorTopicYN="Y">NAV1.5 Voltage-Gated Sodium Channel</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012964" MajorTopicYN="N">Sodium</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Amphipathic</Keyword>
        <Keyword MajorTopicYN="N">arrhythmia</Keyword>
        <Keyword MajorTopicYN="N">capsaicin</Keyword>
        <Keyword MajorTopicYN="N">electrophysiology</Keyword>
        <Keyword MajorTopicYN="N">functional gastrointestinal disorder</Keyword>
        <Keyword MajorTopicYN="N">ion channel</Keyword>
        <Keyword MajorTopicYN="N">irritable bowel syndrome</Keyword>
        <Keyword MajorTopicYN="N">mechanosensitivity</Keyword>
        <Keyword MajorTopicYN="N">mechanotransduction</Keyword>
        <Keyword MajorTopicYN="N">voltage-gated sodium channel type 5</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>12</Day>
          <Hour>12</Hour>
          <Minute>12</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35412435</ArticleId>
        <ArticleId IdType="pmc">PMC9009938</ArticleId>
        <ArticleId IdType="doi">10.1080/19336950.2022.2026015</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Makielski JC, Ye B, Valdivia CR, et al. A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels. Circ Res. 2003;93(9):821–828.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14500339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hille B.
Ionic channels in excitable membranes. Current problems and biophysical approaches. Biophys J. 1978;22(2):283–294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1473440</ArticleId>
            <ArticleId IdType="pubmed">656545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gellens ME, George AL Jr., Chen LQ, et al. Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc Natl Acad Sci U S A. 1992;89(2):554–558.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC48277</ArticleId>
            <ArticleId IdType="pubmed">1309946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farrugia G. Ionic conductances in gastrointestinal smooth muscles and interstitial cells of Cajal. Annu Rev Physiol. 1999;61(1):45–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10099682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beyder A, Rae JL, Bernard C, et al. Mechanosensitivity of Nav1.5, a voltage-sensitive sodium channel. J Physiol. 2010;588(24):4969–4985.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3036191</ArticleId>
            <ArticleId IdType="pubmed">21041530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morris CE, Juranka PF. Nav channel mechanosensitivity: activation and inactivation accelerate reversibly with stretch. Biophys J. 2007;93(3):822–833.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1913161</ArticleId>
            <ArticleId IdType="pubmed">17496023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neshatian L, Strege PR, Rhee PL, et al. Ranolazine inhibits voltage-gated mechanosensitive sodium channels in human colon circular smooth muscle cells. Am J Physiol Gastrointest Liver Physiol. 2015;309(6):G506–512</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4572410</ArticleId>
            <ArticleId IdType="pubmed">26185330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strege PR, Ou Y, Sha L, et al. Sodium current in human intestinal interstitial cells of Cajal. Am. J. Physiol. Gastrointest. Liver Physiol. 2003;285(6):G1111–1121</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12893628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strege PR, Mazzone A, Kraichely RE, et al. Species dependent expression of intestinal smooth muscle mechanosensitive sodium channels. Neurogastroenterol Motil. 2007;19(2):135–143.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17244168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beyder A, Farrugia G. Ion channelopathies in functional GI disorders. Am J Physiol: Gastrointes Liver Physiol. 2016;311:G581–G586.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5142191</ArticleId>
            <ArticleId IdType="pubmed">27514480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kass RS. The channelopathies: novel insights into molecular and genetic mechanisms of human disease. J Clin Invest. 2005;115(8):1986–1989.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1180558</ArticleId>
            <ArticleId IdType="pubmed">16075038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marban E. Cardiac channelopathies. Nature. 2002;415(6868):213–218.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11805845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beyder A, Gibbons SJ, Mazzone A, et al. Expression and function of the Scn5a-encoded voltage-gated sodium channel NaV1.5 in the rat jejunum. Neurogastroenterol Motil. 2016;28(1):64–73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4688076</ArticleId>
            <ArticleId IdType="pubmed">26459913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Banderali U, Juranka PF, Clark RB, et al. Impaired stretch modulation in potentially lethal cardiac sodium channel mutants. Channels (Austin). 2010;4(1):12–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20090423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beyder A, Mazzone A, Strege PR, et al. Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome. Gastroenterology. 2014;146(7):1659–1668.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4096335</ArticleId>
            <ArticleId IdType="pubmed">24613995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saito YA, Strege PR, Tester DJ, et al. Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy. Am. J. Physiol. Gastrointest. Liver Physiol. 2009;296(2):G211–218</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2643921</ArticleId>
            <ArticleId IdType="pubmed">19056759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strege PR, Mercado-Perez A, Mazzone A, et al. SCN5A mutation G615E results in NaV1.5 voltage-gated sodium channels with normal voltage-dependent function yet loss of mechanosensitivity. Channels (Austin). 2019;13(1):287–298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6629189</ArticleId>
            <ArticleId IdType="pubmed">31262209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strege PR, Mazzone A, Bernard CE, et al. Irritable bowel syndrome (IBS) patients have SCN5A channelopathies that lead to decreased NaV1.5 current and mechanosensitivity. Am J Physiol Gastrointest Liver Physiol. 2017;314(4):G494–G503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5966747</ArticleId>
            <ArticleId IdType="pubmed">29167113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beyder A, Mazzone A, Strege PR, et al. Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome. Gastroenterology. 2014;146(7):1659–1668.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4096335</ArticleId>
            <ArticleId IdType="pubmed">24613995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bagal SK, Brown AD, Cox PJ, et al. Ion channels as therapeutic targets: a drug discovery perspective. J Med Chem. 2013;56(3):593–624.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23121096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beyder A, Strege PR, Bernard C, et al. Membrane permeable local anesthetics modulate Na(V)1.5 mechanosensitivity. Channels (Austin). 2012;6(4):308–316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3508909</ArticleId>
            <ArticleId IdType="pubmed">22874086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beyder A, Strege PR, Reyes S, et al. Ranolazine Decreases Mechanosensitivity of the Voltage-Gated Sodium Ion Channel NaV1.5. Circulation. 2012;125(22):2698–2706.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3392778</ArticleId>
            <ArticleId IdType="pubmed">22565935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sukharev S, Sachs F. Molecular force transduction by ion channels: diversity and unifying principles. J Cell Sci. 2012;125(Pt 13):3075–3083.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3434843</ArticleId>
            <ArticleId IdType="pubmed">22797911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kraichely RE, Farrugia G. Mechanosensitive ion channels in interstitial cells of Cajal and smooth muscle of the gastrointestinal tract. Neurogastroenterol Motil. 2007;19(4):245–252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17391240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strege PR, Holm AN, Rich A, et al. Cytoskeletal modulation of sodium current in human jejunal circular smooth muscle cells. Am J Physiol Cell Physiol. 2003;284(1):C60–66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12475760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beyder A, Strege PR, Reyes S, et al. Ranolazine Decreases Mechanosensitivity of the Voltage-Gated Sodium Ion Channel Na(V)1.5. Circulation. 2012;125(22):2698–2706.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3392778</ArticleId>
            <ArticleId IdType="pubmed">22565935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Antzelevitch C, Burashnikov A, Sicouri S, et al. Electrophysiologic basis for the antiarrhythmic actions of ranolazine. Heart Rhythm. 2011;8(8):1281–1290.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3131428</ArticleId>
            <ArticleId IdType="pubmed">21421082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rusinova R, Koeppe RE 2nd, Andersen OS. A general mechanism for drug promiscuity: studies with amiodarone and other antiarrhythmics. J Gen Physiol. 2015;146(6):463–475.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4664825</ArticleId>
            <ArticleId IdType="pubmed">26573624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kraichely RE, Strege PR, Sarr MG, et al. Lysophosphatidyl choline modulates mechanosensitive L-type Ca2+ current in circular smooth muscle cells from human jejunum. Am J Physiol Gastrointest Liver Physiol. 2009;296(4):G833–839.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2670668</ArticleId>
            <ArticleId IdType="pubmed">19179622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nash DT, Nash SD. Ranolazine for chronic stable angina. Lancet. 2008;372(9646):1335–1341.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18929905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greene HL, Graham EL, Werner JA, et al. Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias. J Am Coll Cardiol. 1983;2:1114–1128.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6685151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abrahamsson H, Dotevall G. Effects of propranolol on colonic pressure in patients with irritable bowel syndrome. Scand J Gastroenterol. 1981;16(8):1021–1024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7336128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rusinova R, Herold KF, Sanford RL, et al. Thiazolidinedione insulin sensitizers alter lipid bilayer properties and voltage-dependent sodium channel function: implications for drug discovery. J Gen Physiol. 2011;138(2):249–270.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3149818</ArticleId>
            <ArticleId IdType="pubmed">21788612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ho YF, Chou HY, Chu JS, et al. Comedication with interacting drugs predisposes amiodarone users in cardiac and surgical intensive care units to acute liver injury: a retrospective analysis. Medicine (Baltimore). 2018;97(37):e12301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avdeef A, Box KJ, Comer JE, et al. pH-metric logP 10. Determination of liposomal membrane-water partition coefficients of ionizable drugs. Pharm Res. 1998;15(2):209–215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9523305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PubChem . PubChem Compound Summary for CID 5590. Octoxinol NIH: National Library of Medicine; 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>LaHann TR, DeKrey LJ, Tarr BD. Capsaicin analgesia: predictions based on physico-chemical properties. Proc West Pharmacol Soc. 1989;32:201–204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2780588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang DW, Mistry AM, Kahlig KM, et al. Propranolol blocks cardiac and neuronal voltage-gated sodium channels. Front Pharmacol. 2010;1:144.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3153018</ArticleId>
            <ArticleId IdType="pubmed">21833183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang XC, Sachs F. Block of stretch-activated ion channels in xenopus oocytes by gadolinium and calcium ions. Science. 1989;243(4894):1068–1071.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2466333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lundbaek JA, Collingwood SA, Ingolfsson HI, et al. Lipid bilayer regulation of membrane protein function: gramicidin channels as molecular force probes. J R Soc Interface. 2010;7(44):373–395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2842803</ArticleId>
            <ArticleId IdType="pubmed">19940001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lundbaek JA, Koeppe RE 2nd, Andersen OS. Amphiphile regulation of ion channel function by changes in the bilayer spring constant. Proc Natl Acad Sci U S A. 2010;107(35):15427–15430.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2932597</ArticleId>
            <ArticleId IdType="pubmed">20713738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lundbaek JA, Birn P, Tape SE, et al. Capsaicin regulates voltage-dependent sodium channels by altering lipid bilayer elasticity. Mol Pharmacol. 2005;68(3):680–689.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15967874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kapoor R, Peyear TA, Koeppe RE 2nd, et al. Antidepressants are modifiers of lipid bilayer properties. J Gen Physiol. 2019;151(3):342–356.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang C, Zhang X, Guo Y, et al. Mechanical dynamics in live cells and fluorescence-based force/tension sensors. Biochim Biophys Acta. 2015;1853(8):1889–1904.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4841255</ArticleId>
            <ArticleId IdType="pubmed">25958335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suchyna TM, Markin VS, Sachs F. Biophysics and structure of the patch and the gigaseal. Biophys J. 2009;97(3):738–747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2718145</ArticleId>
            <ArticleId IdType="pubmed">19651032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morris CE. Voltage-gated channel mechanosensitivity: fact or friction?
Front Physiol. 2011;2:25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3107450</ArticleId>
            <ArticleId IdType="pubmed">21660289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sokabe M, Sachs F. The structure and dynamics of patch-clamped membranes: a study using differential interference contrast light microscopy. J Cell Biol. 1990;111(2):599–606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2116211</ArticleId>
            <ArticleId IdType="pubmed">2380245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beyder A, Rae JL, Bernard C, et al. Mechanosensitivity of Nav1.5, a voltage-sensitive sodium channel. J Physiol. 2010;588(24):4969–4985.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3036191</ArticleId>
            <ArticleId IdType="pubmed">21041530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamkin A, Kiseleva I. Mechanosensitivity of Cells from Various Tissues. In: Kamkin A, and Kiseleva I, editors. Mechanosensitivity in Cells and Tissues. Moscow: Academia;2005: 5-7695-2590-8. https://www.ncbi.nlm.nih.gov/books/NBK7493/.</Citation>
        </Reference>
        <Reference>
          <Citation>Joshi V, Strege PR, Farrugia G, et al. Mechanotransduction in gastrointestinal smooth muscle cells: role of mechanosensitive ion channels. Am J Physiol Gastrointest Liver Physiol. 2021;320(5):G897–G906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8202201</ArticleId>
            <ArticleId IdType="pubmed">33729004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abriel H. Cardiac Sodium Channel Na(v)1.5 Mechanosensitivity Is Inhibited by Ranolazine. Circulation. 2012;125(22):2681–2683.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22565937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fozzard HA, Sheets MF, Hanck DA. The sodium channel as a target for local anesthetic drugs. Front Pharmacol. 2011;2:68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3205381</ArticleId>
            <ArticleId IdType="pubmed">22053156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strichartz GR. The inhibition of sodium currents in myelinated nerve by quaternary derivatives of lidocaine. J Gen Physiol. 1973;62(1):37–57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2226105</ArticleId>
            <ArticleId IdType="pubmed">4541340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tikhonov DB, Zhorov BS. Mechanism of sodium channel block by local anesthetics, antiarrhythmics, and anticonvulsants. J Gen Physiol. 2017;149(4):465–481.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5379917</ArticleId>
            <ArticleId IdType="pubmed">28258204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stefan MI, Le Novere N. Cooperative binding. PLoS Comput Biol. 2013;9(6):e1003106.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3699289</ArticleId>
            <ArticleId IdType="pubmed">23843752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rusinova R, He C, Andersen OS. Mechanisms underlying drug-mediated regulation of membrane protein function. Proc Natl Acad Sci U S A. 2021;118(46):e2113229118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8609545</ArticleId>
            <ArticleId IdType="pubmed">34753824</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sachs F. Mechanical Transduction and the Dark Energy of Biology. Biophys J. 2018;114(1):3–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5984904</ArticleId>
            <ArticleId IdType="pubmed">29320693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burashnikov A, Di Diego JM, Zygmunt AC, et al. Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine. Circulation. 2007;116(13):1449–1457.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2566303</ArticleId>
            <ArticleId IdType="pubmed">17785620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gawali VS, Lukacs P, Cervenka R, et al. Mechanism of Modification, by Lidocaine, of Fast and Slow Recovery from Inactivation of Voltage-Gated Na(+) Channels. Mol Pharmacol. 2015;88(5):866–879.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26358763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sheets MF, Hanck DA. Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels. J Physiol. 2007;582(1):317–334.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2075305</ArticleId>
            <ArticleId IdType="pubmed">17510181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peters CH, Sokolov S, Rajamani S, et al. Effects of the antianginal drug, ranolazine, on the brain sodium channel Na(V)1.2 and its modulation by extracellular protons. Br J Pharmacol. 2013;169(3):704–716.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3682716</ArticleId>
            <ArticleId IdType="pubmed">23472826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dimitrakopoulos P. Analysis of the variation in the determination of the shear modulus of the erythrocyte membrane: effects of the constitutive law and membrane modeling. Phys Rev E Stat Nonlin Soft Matter Phys. 2012;85(4):041917.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3605755</ArticleId>
            <ArticleId IdType="pubmed">22680508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bavi N, Nakayama Y, Bavi O, et al. Biophysical implications of lipid bilayer rheometry for mechanosensitive channels. Proc Natl Acad Sci U S A. 2014;111(38):13864–13869.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4183281</ArticleId>
            <ArticleId IdType="pubmed">25201991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haswell ES, Phillips R, Rees DC. Mechanosensitive channels: what can they do and how do they do it?
Structure. 2011;19(10):1356–1369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3203646</ArticleId>
            <ArticleId IdType="pubmed">22000509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perozo E, Cortes DM, Sompornpisut P, et al. Open channel structure of MscL and the gating mechanism of mechanosensitive channels. Nature. 2002;418(6901):942–948.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12198539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinac B, Adler J, Kung C. Mechanosensitive ion channels of E. coli activated by amphipaths. Nature. 1990;348(6298):261–263.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1700306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kohl P, Sachs F, Franz MR. Cardiac mechano-electric feedback and arrhythmias: from pipette to patient. 1st ed. Philadelphia PA: W.B. Saunders; 2005.</Citation>
        </Reference>
        <Reference>
          <Citation>Franz MR. Mechano-electrical feedback. Cardiovasc Res. 2000;45(2):263–266.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10728344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gonlachanvit S, Mahayosnond A, Kullavanijaya P. Effects of chili on postprandial gastrointestinal symptoms in diarrhoea predominant irritable bowel syndrome: evidence for capsaicin-sensitive visceral nociception hypersensitivity. Neurogastroenterol Motil. 2009;21(1):23–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18647268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nikolaev YA, Cox CD, Ridone P, et al. Mammalian TRP ion channels are insensitive to membrane stretch. J Cell Sci. 2019;132(23): jcs238360.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6918743</ArticleId>
            <ArticleId IdType="pubmed">31722978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mazzone A, Gibbons SJ, Eisenman ST, et al. Direct repression of anoctamin 1 (ANO1) gene transcription by Gli proteins. FASEB J. 2019;33(5):6632–6642.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agarwal MK, Bhatia SJ, Desai SA, et al. Effect of red chillies on small bowel and colonic transit and rectal sensitivity in men with irritable bowel syndrome. Indian J. Gastroenterol. 2002;21(5):179–182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12416746</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aniwan S, Gonlachanvit S. Effects of Chili Treatment on Gastrointestinal and Rectal Sensation in Diarrhea-predominant Irritable Bowel Syndrome: a Randomized, Double-blinded, Crossover Study. J Neurogastroenterol Motil. 2014;20(3):400–406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4102147</ArticleId>
            <ArticleId IdType="pubmed">24867591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patcharatrakul T, Gonlachanvit S. Chili Peppers, Curcumins, and Prebiotics in Gastrointestinal Health and Disease. Curr Gastroenterol Rep. 2016;18(4):19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26973345</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spencer NJ, Hu H. Enteric nervous system: sensory transduction, neural circuits and gastrointestinal motility. Nat Rev Gastroenterol Hepatol. 2020;17(6):338–351.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7474470</ArticleId>
            <ArticleId IdType="pubmed">32152479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beyder A, Farrugia G. Ion channelopathies in functional GI disorders. Am J Physiol Gastrointest Liver Physiol. 2016;311(4):G581–G586.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5142191</ArticleId>
            <ArticleId IdType="pubmed">27514480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Locke GR 3rd, Ackerman MJ, Zinsmeister AR, et al. Gastrointestinal symptoms in families of patients with an SCN5A-encoded cardiac channelopathy: evidence of an intestinal channelopathy. Am J Gastroenterol. 2006;101(6):1299–1304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16771953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alper SL. Genetic Diseases of PIEZO1 and PIEZO2 Dysfunction. Curr Top Membr. 2017;79:97–134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28728825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zarychanski R, Schulz VP, Houston BL, et al. Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis. Blood. 2012;120(9):1908–1915.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3448561</ArticleId>
            <ArticleId IdType="pubmed">22529292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bae C, Gnanasambandam R, Nicolai C, et al. Xerocytosis is caused by mutations that alter the kinetics of the mechanosensitive channel PIEZO1. Proc Natl Acad Sci U S A. 2013;110(12):E1162–1168.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3606986</ArticleId>
            <ArticleId IdType="pubmed">23487776</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
